Angiogenic markers in non-small cell lung cancer: evaluation of clinical and prognostic impacts
- Prosjektnummer
- SFP872-09
- Ansvarlig person
- Roy M. Bremnes
- Institusjon
- Universitetssykehuset Nord-Norge HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 1. Underpinning
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.
BMC Clin Pathol 2012;12():5. Epub 2012 feb 29
PMID: 22375962
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.
BMC Clin Pathol 2012;12():7. Epub 2012 mai 3
PMID: 22554285
High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.
Oncoimmunology 2012 Jan;1(1):75-77.
PMID: 22720216
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
PLoS One 2012;7(10):e47068. Epub 2012 okt 5
PMID: 23071715
Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Sarcoma 2012;2012():541650. Epub 2012 feb 20
PMID: 22454562
[Mutation testing for non-small-cell lung cancer].
Tidsskr Nor Laegeforen 2012 Apr;132(8):952-5.
PMID: 22562326
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology.
Anticancer Res 2012 Nov;32(11):4729-36.
PMID: 23155236
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.
Lung Cancer 2012 Feb;75(2):235-41. Epub 2011 jul 18
PMID: 21764478
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.
J Thorac Dis 2012 Apr;4(2):212-3.
PMID: 22833829
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.
PLoS One 2012;7(1):e29671. Epub 2012 jan 25
PMID: 22295063
Bridging the distance: a prospective tele-oncology study in Northern Norway.
Support Care Cancer 2011 Nov. Epub 2011 nov 11
PMID: 22076621
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.
J Transl Med 2011;9():200. Epub 2011 nov 22
PMID: 22107784
The prognostic impact of TGF-ß1, fascin, NF-?B and PKC-? expression in soft tissue sarcomas.
PLoS One 2011;6(3):e17507. Epub 2011 mar 3
PMID: 21390241
Prognostic impact of lymphocytes in soft tissue sarcomas.
PLoS One 2011;6(1):e14611. Epub 2011 jan 27
PMID: 21298041
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas.
Int J Oncol 2011 Apr;38(4):1031-40. Epub 2011 jan 24
PMID: 21271213
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Lung Cancer 2011 Jun;72(3):294-302. Epub 2010 nov 13
PMID: 21075472
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
J Transl Med 2011;9():104. Epub 2011 jul 6
PMID: 21733164
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
J Thorac Oncol 2011 Apr;6(4):824-33.
PMID: 21173711
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.
PLoS One 2011;6(5):e19773. Epub 2011 mai 16
PMID: 21603628
Correlation and coexpression of HIFs and NOTCH markers in NSCLC.
Anticancer Res 2011 May;31(5):1603-6.
PMID: 21617216
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
PLoS One 2011;6(8):e23847. Epub 2011 aug 22
PMID: 21887331
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.
J Thorac Oncol 2011 Jan;6(1):209-17.
PMID: 21107292
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
Clin Lung Cancer 2011 Mar;12(2):106-15. Epub 2011 apr 11
PMID: 21550557
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.
J Transl Med 2011;9():6. Epub 2011 jan 10
PMID: 21219656
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.
Cancer 2011 Jul;117(14):3193-200. Epub 2011 jan 24
PMID: 21264844
The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
APMIS 2010 May;118(5):371-82.
PMID: 20477813
Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.
J Thorac Oncol 2010 Oct;5(10):1536-43.
PMID: 20802349
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
PLoS One 2010;5(12):e15368. Epub 2010 des 14
PMID: 21179485
Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.
Cancer 2010 Sep;116(18):4318-25.
PMID: 20549821
Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Cancer 2010 Dec;116(24):5676-85. Epub 2010 aug 24
PMID: 20737536
Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.
Ann Oncol 2010 Feb;21(2):223-31. Epub 2009 jul 23
PMID: 19628565
Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.
Anticancer Res 2009 Oct;29(10):4175-83.
PMID: 19846969
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Histopathology 2009 Sep;55(3):301-12.
PMID: 19723145
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
J Thorac Oncol 2009 Apr;4(4):463-71.
PMID: 19204576
VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.
Lung Cancer 2009 Feb;63(2):277-83. Epub 2008 jul 2
PMID: 18599153
Immunohistochemical Expression of ErbB Family Receptors in Non-Small Cell Lung Cancer (NSCLC).
BIT's 2nd Annual Congress and Expo of Molecular Diagnostics (CEMD-2009). Beijing, China, November 2009.
Prognostic impact of Epithelial and Stromal Lymphocyte Infiltration in NSCLC.
European congress of pathology, Florence, Italy, Sept 2009.
The Prognostic Impact of NFkB p105, Vimentin, E-cadherin and Par6 Expression in Epithelial and Stromal Compartment in NSCLC.
European congress of pathology, Florence, Italy, Sept 2009.
Diverse Prognostic Roles of Akt Isoforms, PTEN and PI3K in Tumor Epithelial Cells and Stromal Compartment in NSCLC
European congress of pathology, Florence, Italy, Sept 2009.
The Prognostic Value of Intraepithelial and Stromal CD3, CD117 and CD138 Positive Cells in Non-Small Cell Lung Carcinoma.
European congress of pathology, Florence, Italy, Sept 2009.
Angiogenic marker expression in tumor cells versus stromal cells in non-small cell lung cancer.
13th world conference on lung cancer, San Fransisco, CA, USA. Journal of thoracic oncology. Abstract P1.083; 4(9): S5-S1023, September 2009.
Diverging prognostic impacts of hypoxic markers in histologic non-small cell lung cancer (NSCLC) subtypes.
13th world conference on lung cancer, San Fransisco, CA, USA. Journal of thoracic oncology. Abstract D3.4; 4(9): S5-S1023, September 2009. doi:10.1097
The Prognostic Value of Intraepithelial and Stromal Innate Immune System Cells in Non-Small Cell Lung Carcinoma.
Scientific Conference of Helse Nord, Tromsø, Norway, 2009.
The Prognostic Impact of NFkB p105, Vimentin, E-cadherin and Par6 Expression in Epithelial and Stromal Compartment in NSCLC.
Scientific Conference of Helse Nord, Tromsø, Norway, 2009.
Prognostic Impact of Fibroblast Growth Factor 2 in NSCLC: Co-Expression with VEGFR-3 and PDGF-B Predicts Poor Survival.
Scientific Conference of Helse Nord, Tromsø, Norway, 2009.
Co-expression of PDGF-B / VEGFR-3 strongly correlate with lymph node metastasis and poor survival in non-small cell lung cancer
AACR, Denver, USA, May 2009.
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord